American depositary receipts (ADRs) of Novo Nordisk (NVO) jumped over 4% in pre-market trading this morning after reporting a healthy sales ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd. (BABA), ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

The report lays the groundwork for Wednesday's heavily anticipated CPI print. Meanwhile ... fourth quarter sales of its weight-loss drug Zepbound were expected to come in below Wall Street ...

A softer-than-expected Producer Price Index (PPI) print boosted equity futures on ... potential of its obesity and Type 2 diabetes drugs, Zepbound and Mounjaro. For the fourth quarter, Eli Lilly ...

In a recent press release, Eli Lilly's management said that the U.S. incretin market, which includes drugs like Zepbound and Mounjaro, didn't grow as fast as it anticipated in the fourth quarter.

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

Zepbound is an injectable prescription medication created to help adults with obesity and weight-related problems, including obstructive sleep apnea. OSA causes airway collapses during sleep and ...